Series A - Alphyn Biologics
Investment Firm
Overview
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.
Announced Date
Sep 15, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Queen City Angels |
Round Details and Background
Alphyn Biologics raised $3300000 on 2022-09-15 in Series A
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 20, 2022 |  Venture Round - Alphyn Biologics | - | 2.2M | |
| Sep 15, 2022 | Series A - Alphyn Biologics | 3 | - | 3.3M |
| Apr 04, 2024 | Venture Round - Alphyn Biologics | - | 5.2M | |
| May 24, 2023 | Venture Round - Alphyn Biologics | - | 1.2M |
Recent Activity
There is no recent news or activity for this profile.